Evidence map›Paper›PMID 39075486›Full record

ArticleJournal of translational medicine2024

Radiogenomic analysis for predicting lymph node metastasis and molecular annotation of radiomic features in pancreatic cancer.

Yi Tang, Yi-Xi Su, Jin-Mei Zheng, Min-Ling Zhuo, Qing-Fu Qian, Qing-Ling Shen, Peng Lin, Zhi-Kui Chen

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Yi Tang *Department of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Yi-Xi Su *Department of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Jin-Mei ZhengDepartment of Radiology, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Min-Ling ZhuoDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Qing-Fu QianDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Qing-Ling ShenDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China.
Peng LinDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China. linpeng@fjmu.edu.cn.
Zhi-Kui ChenDepartment of Medical Ultrasound, Fujian Medical University Union Hospital, 29 Xinquan road, Fuzhou, China. jimchen2003@163.com.

Funding

Fujian Medical University Union Hospital Talent Launch Fund Project Fujian Medical University Union Hospital Talent Launch Fund ProjectJoint Funds for the innovation of science and Technology, Fujian province 2019Y9066
6 · The paper itself

Abstract

backgroundTo provide a preoperative prediction model for lymph node metastasis in pancreatic cancer patients and provide molecular information of key radiomic features.

methodsTwo cohorts comprising 151 and 54 pancreatic cancer patients were included in the analysis. Radiomic features from the tumor region of interests were extracted by using PyRadiomics software. We used a framework that incorporated 10 machine learning algorithms and generated 77 combinations to construct radiomics-based models for lymph node metastasis prediction. Weighted gene coexpression network analysis (WGCNA) was subsequently performed to determine the relationships between gene expression levels and radiomic features. Molecular pathways enrichment analysis was performed to uncover the underlying molecular features.

resultsPatients in the in-house cohort (mean age, 61.3 years ± 9.6 [SD]; 91 men [60%]) were separated into training (n = 105, 70%) and validation (n = 46, 30%) cohorts. A total of 1,239 features were extracted and subjected to machine learning algorithms. The 77 radiomic models showed moderate performance for predicting lymph node metastasis, and the combination of the StepGBM and Enet algorithms had the best performance in the training (AUC = 0.84, 95% CI = 0.77-0.91) and validation (AUC = 0.85, 95% CI = 0.73-0.98) cohorts. We determined that 15 features were core variables for lymph node metastasis. Proliferation-related processes may respond to the main molecular alterations underlying these features.

conclusionsMachine learning-based radiomics could predict the status of lymph node metastasis in pancreatic cancer, which is associated with proliferation-related alterations.

Indexed as

Lymphatic MetastasisPancreatic NeoplasmsAgedAlgorithmsCohort StudiesFemaleGene Expression Regulation, NeoplasticGene Regulatory NetworksGenomicsHumansMachine LearningMaleMiddle AgedMolecular Sequence AnnotationRadiomicsReproducibility of ResultsBiological interpretabilityPancreatic cancerRadiomics

Identifiers

PMID39075486
PMCPMC11288107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.